Nova Eye Medical

In this study from doctors Mark Gallardo ????, Mahmoud A. Khaimi, MD ????, Norbert Koerber ???? and Simon Ondrejka ????, a whopping 98% of eyes saw IOP reduction over 12 months. The key takeaway? The ability of canaloplasty to treat multiple sites of obstruction in the conventional outflow pathway may offer the advantage of greater consistency in outcomes. . . . . . . . . . . . . . . . . . . . . The iTrack? Advance has a CE Mark (Conformité Européenne) and US Food and Drug Administration (FDA) 510(k) #K221872 for the treatment of open-angle glaucoma. The iTrack? Advance is indicated for fluid infusion or aspiration during surgery. The iTrack? Advance is indicated for the cutting or disruption of the trabecular meshwork during goniotomy procedures.* The iTrack? Advance is indicated for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in adult patients with open-angle glaucoma. * The iTrack? Advance cutting function (goniotomy) is a Class 1 510(k) exempt device function that is not specifically indicated for the reduction of intraocular pressure (IOP) or the treatment of open-angle glaucoma. For full safety information, please visit: https://lnkd.in/gKWZaHGc #canaloplasty #glaucoma #itrackadvance #itrack

?? Today is World Glaucoma Day—a reminder that early detection is key to preserving vision! ?? Glaucoma is the leading cause of irreversible blindness worldwide, yet many people don’t even realize they have it until it’s too late. Regular eye exams and innovative treatment options are crucial in the fight against this silent thief of sight. Let’s continue raising awareness and supporting advancements that help protect our vision! #WorldGlaucomaDay #GlaucomaAwareness #iTrackAdvance #canaloplasty #NovaEyeMedical

?? As we celebrate International Women's Day, it's the perfect time to acknowledge the incredible women who are shaping the future of ophthalmology. From pioneering groundbreaking research to leading innovative surgical techniques, women have made profound contributions to the field of ophthalmology. These women are not only experts in their field but also champions for change, empowering the next generation of ophthalmologists and improving patient care worldwide. Their strength, resilience, and passion continue to inspire us all. Let’s take a moment to appreciate the powerful impact of women in the ophthalmic community. Tag a woman in ophthalmology who inspires you! ?? Happy International Women’s Day! ?? #IWD2025 #Strength #iTrackAdvance #NovaEyeMedical #MIGS #canaloplasty

♀? This International Women’s Day, we celebrate the trailblazing women whose contributions are reshaping glaucoma surgery. ♀? Trailblazing women don’t wait for doors to open—they create their own paths and make space for others to follow. ♀? Trailblazing women are changing the landscape of glaucoma treatment and creating lasting legacies in ophthalmology. #IWD2025 #Strength #iTrackAdvance #NovaEyeMedical #MIGS #canaloplasty

♀? As International Women’s Day draws nearer, we honor the empowerment of women in ophthalmology. An empowered woman is a force of nature—she knows her worth, uses her voice, and uplifts those around her. And in the world of ophthalmology, their leadership in education, mentorship, and advocacy has made significant strides in improving patient care. ??? Empowered women are building a brighter future in ophthalmology. #IWD2025 #Strength #iTrackAdvance #NovaEyeMedical #MIGS #canaloplasty

♀? ?? Ahead of International Women’s Day on March 8, 2025, we are celebrating the strength of women in ophthalmology. Strength is the foundation of leadership, progress, and change. Let’s raise a toast to the incredible community of women in ophthalmology who continue to stand tall in the face of adversity and push the boundaries of what ophthalmic technology can accomplish. #IWD2025 #Strength #iTrackAdvance #NovaEyeMedical #MIGS #canaloplasty

?????? ?? Ed Yung, MD, from Pacific Eye Institute in California knows a thing or two about canaloplasty and its utility in the treatment of mild-moderate glaucoma. In this video, the discusses the ins and outs of patient selection and offers practical insights. He also explains why the iTrack? Advance has become his go-to choice for canaloplasty. . . . . . . . . . . . . . . . . . . . . The iTrack? Advance has a CE Mark (Conformité Européenne) and US Food and Drug Administration (FDA) 510(k) #K221872 for the treatment of open-angle glaucoma. The iTrack? Advance is indicated for fluid infusion or aspiration during surgery. The iTrack? Advance is indicated for the cutting or disruption of the trabecular meshwork during goniotomy procedures.* The iTrack? Advance is indicated for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in adult patients with open-angle glaucoma. * The iTrack? Advance cutting function (goniotomy) is a Class 1 510(k) exempt device function that is not specifically indicated for the reduction of intraocular pressure (IOP) or the treatment of open-angle glaucoma. For full safety information, please visit: https://lnkd.in/gKWZaHGc #canaloplasty #glaucoma #itrackadvance #itrack

????? Six years and counting... B.O.O.M. This was one of several compelling iTrack? Advance data sets presented at the recent 2025 annual meeting of the American Glaucoma Society (AGS) in Washington D.C. Brilliant data aside, it is such a treat for Nova Eye to partner with progressive surgeons such as James Murphy, MD, FAAO, FACS to highlight the clinical merits of canaloplasty!! . . . . . . . . . . . . . . . . . . . . The iTrack? Advance has a CE Mark (Conformité Européenne) and US Food and Drug Administration (FDA) 510(k) #K221872 for the treatment of open-angle glaucoma. The iTrack? Advance is indicated for fluid infusion or aspiration during surgery. The iTrack? Advance is indicated for the cutting or disruption of the trabecular meshwork during goniotomy procedures.* The iTrack? Advance is indicated for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in adult patients with open-angle glaucoma. * The iTrack? Advance cutting function (goniotomy) is a Class 1 510(k) exempt device function that is not specifically indicated for the reduction of intraocular pressure (IOP) or the treatment of open-angle glaucoma. For full safety information, please visit: https://lnkd.in/gKWZaHGc #canaloplasty #glaucoma #itrackadvance #itrack

?? We're excited to be at AGS—canaloplasty is on fire, and so is our team! #AGS2025 It’s great catching up with old friends and meeting new ones in DC. ?? Swing by Exhibit No. 37 and say hi! #iTrackAdvance #canaloplasty #NovaEyeMedical

? ? The countdown is on! #AGS2025 Washington D.C. features some of the world’s most famous monuments and memorials… and now it also features the iTrack? Advance! The Nova Eye Medical team will travel to Washington D.C. next week for the 2025 annual meeting of the American Glaucoma Society (AGS). Join us as we continue to redefine MIGS with the iTrack? Advance for canaloplasty, the only MIGS procedure designed to target and treat all possible points of outflow resistance in the conventional outflow pathway, including the collector channels.? ? Come visit us to learn more about iTrack? Advance and why it is the original masterpiece of canaloplasty. See you in D.C.!????? ???Find us at Booth 37 ???Dates: February 27 – March 1 ? #AGS2025 #Glaucoma #MIGS #Canaloplasty #iTrackAdvance #NovaEyeMedical ?